|
|
Yes (n=70)
|
No
(n=463)
|
|
|
|
|
Gender; n (%) |
Gender; n (%) |
Gender; n
(%) |
Gender; n (%) |
|
|
|
|
Male |
279 (52.3) |
46 (65.7) |
233 (50.3) |
1.89 (1.12-3.20) |
0.018 |
1.58 (0.82-3.06) |
0.170 |
Female |
254 (47.7) |
24 (34.3) |
230 (49.7) |
1 |
|
1 |
|
Age; n (%) |
|
|
|
|
|
|
|
Age <60 years |
478 (89.7) |
51 (72.9) |
427 (92.2) |
1 |
|
1 |
|
Age ≥60 years |
55 (10.3) |
19 (27.1) |
36 (7.8) |
4.42 (2.36-8.27) |
<0.001 |
1.93 (0.86-4.33) |
0.111 |
Underlying risk condition; n (%) |
Underlying risk
condition; n (%) |
Underlying risk condition; n (%) |
Underlying risk condition; n (%) |
|
|
|
|
Yes |
120 (22.5) |
34 (48.6) |
86 (18.6) |
4.14 (2.45-6.99) |
<0.001 |
1.95 (1.01-3.73) |
0.045 |
No |
413 (77.5) |
36 (51.4) |
277 (81.4) |
1 |
|
1 |
|
Obesity; n (%) |
|
|
|
|
|
|
|
Yes |
40 (7.5) |
11 (15.7) |
29 (6.3) |
2.79 (1.32-5.88) |
0.007 |
- |
- |
No |
493 (92.5) |
59 (84.3) |
434 (93.7) |
1 |
|
- |
|
Presented with pneumonia; n (%) |
Presented with
pneumonia; n (%) |
Presented with pneumonia; n (%) |
Presented with pneumonia; n (%) |
|
|
|
|
Yes |
159 (29.8) |
54 (77.1) |
105 (22.7) |
11.51 (6.32-20.94) |
<0.001 |
1.90 (0.88-4.11) |
0.103 |
No |
374 (70.2) |
16 (22.9) |
358 (77.3) |
1 |
|
1 |
|
Time from onset of symptoms to hospital admission; n (%) |
Time from onset of symptoms to hospital admission; n (%) |
Time from onset of symptoms to hospital admission; n (%) |
Time from onset of symptoms to hospital admission; n (%) |
|
|
|
|
Within 4 days |
284/531 (53.5) |
20/70 (28.6) |
264/461 (57.3) |
0.30
(0.17-0.52) |
<0.001 |
0.44 (0.23-0.84) |
0.014 |
>4 days |
247/531 (46.5) |
50/70 (71.4) |
197/461 (42.7) |
1 |
|
1 |
|
Initial antiviral regimen; n (%) |
Initial antiviral
regimen; n (%) |
Initial antiviral regimen; n (%) |
Initial antiviral regimen; n (%) |
|
|
|
|
With FPV |
138/384 (35.9) |
54 (79.4) |
84 (26.6) |
10.65 (5.62-20.17) |
<0.001 |
5.31 (2.44-11.56) |
<0.001 |
Non-FPV |
246/384 (64.1) |
14 (20.6) |
232 (73.4) |
1 |
|
1 |
|
Received Azithromycin; n (%) |
Received Azithromycin;
n (%) |
Received Azithromycin; n (%) |
Received
Azithromycin; n (%) |
|
|
|
|
Yes |
129 (24.2) |
37 (52.9) |
92
(19.9) |
4.52 (2.68-7.62) |
<0.001 |
2.22 (1.17-4.21) |
0.014 |
No |
404 (75.8) |
33 (47.1) |
371 (80.1) |
1 |
|
1 |
|